Full name
XENSTATS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
XENSTATS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. OTWARTA 1, 60-008 POZNAŃ
TAX ID7792505356
Rate company:
XENSTATS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7792505356
KRS0000783448
Share capital5,000.00 zł
address
UL. OTWARTA 1, 60-008 POZNAŃ
Website
xenstats.comCategories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7792505356
REGON
383181648
KRS
0000783448
Legal form
limited liability company
Register Address
UL. OTWARTA 1, 60-008 POZNAŃ
Date of registration in KRS
2019-04-24
Date of commencement of economic activity
2019-04-24
Act signature
RDF/626350/24/515
Website
XENSTATS.COM
Pkd codes
72.11.Z - Research and experimental development on biotechnology
62.01.Z - Computer programming activities
62.02.Z - Computer consultancy activities
71.20.B - Other technical testing and analysis
72.19.Z - Other research and experimental development on natural sciences and engineering
85.59.B - Other out-of-school forms of education, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL17 1140 2004 0000 3302 7874 1050 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2020 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 16,9 | 61,4 | 21,2 | -65,5 |
EBITDA | 62,6 | 27,3 | -56,4 | |
Short time liabilities | 1 | 5,1 | 19 | 272,6 |
Equity capital | 20,4 | 148 | 158,1 | 6,8 |
Operating profit (EBIT) | 16,9 | 62,6 | 27,3 | -56,4 |
Assets | 21,4 | 153,1 | 177 | 15,7 |
Net profit (loss) | 15,8 | 55,7 | 18,1 | -67,5 |
Cash | 19,4 | 117,3 | 147,7 | 25,9 |
Net income from sale | 37 | 190,4 | 169,9 | -10,8 |
Liabilities and provisions for liabilities | 1 | 5,1 | 19 | 272,6 |
Working assets | 21,4 | 153,1 | 169,5 | 10,8 |
Depreciation | 0 | 0 | 0 | |
% | % | % | p.p. | |
Profitability of capital | 77,7 | 37,6 | 11,4 | -26,2 |
Equity capital to total assets | 95,2 | 96,7 | 89,3 | -7,4 |
Gross profit margin | 45,7 | 32,3 | 12,5 | -19,8 |
EBITDA Margin | 32,9 | 16,1 | -16,8 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 10 | 10 | 41 | 31 |
Current financial liquidity indicator | 30.041810989379883 | 8.928633689880371 | -21,1 | |
Net dept to EBITDA | -1.8727922439575195 | -5.412616729736328 | -3,5 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Mariusz Rogała
GDAŃSK
Wojciech Gładysz SCRA
Piskórka
FRONTLINE BIOSCIENCES SPÓŁKA AKCYJNA
WARSZAWA
Magdalena Antonijczuk-Krzyśków
TYNIEC MAŁY
BioCraft Paweł Olszewski
Chwaszczyno
KATARZYNA PAWEŁCZYK SCINT
Wrocław